USANA Health Sciences Net Profit Margin 2012-2025 | USNA

USANA Health Sciences net profit margin from 2012 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
USANA Health Sciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-12-31 $0.93B $0.01B 1.08%
2025-09-30 $0.91B $0.02B 1.75%
2025-06-30 $0.90B $0.03B 3.78%
2025-03-31 $0.88B $0.03B 3.88%
2024-12-31 $0.86B $0.04B 4.91%
2024-09-30 $0.86B $0.06B 6.38%
2024-06-30 $0.88B $0.06B 6.29%
2024-03-31 $0.90B $0.06B 6.89%
2023-12-31 $0.92B $0.06B 6.85%
2023-09-30 $0.93B $0.06B 6.36%
2023-06-30 $0.95B $0.06B 6.65%
2023-03-31 $0.97B $0.07B 6.68%
2022-12-31 $1.00B $0.07B 6.91%
2022-09-30 $1.04B $0.08B 7.33%
2022-06-30 $1.08B $0.09B 8.16%
2022-03-31 $1.15B $0.11B 9.30%
2021-12-31 $1.19B $0.12B 9.78%
2021-09-30 $1.23B $0.14B 11.06%
2021-06-30 $1.26B $0.14B 11.16%
2021-03-31 $1.18B $0.13B 11.05%
2020-12-31 $1.14B $0.13B 11.09%
2020-09-30 $1.10B $0.12B 10.68%
2020-06-30 $1.06B $0.11B 10.40%
2020-03-31 $1.06B $0.10B 9.76%
2019-12-31 $1.06B $0.10B 9.43%
2019-09-30 $1.09B $0.10B 9.27%
2019-06-30 $1.13B $0.11B 9.60%
2019-03-31 $1.17B $0.12B 10.34%
2018-12-31 $1.19B $0.13B 10.60%
2018-09-30 $1.16B $0.09B 7.57%
2018-06-30 $1.13B $0.08B 7.18%
2018-03-31 $1.08B $0.07B 6.46%
2017-12-31 $1.05B $0.06B 5.92%
2017-09-30 $1.03B $0.09B 8.76%
2017-06-30 $1.02B $0.10B 9.42%
2017-03-31 $1.02B $0.10B 9.70%
2016-12-31 $1.01B $0.10B 9.94%
2016-09-30 $0.99B $0.10B 10.34%
2016-06-30 $0.97B $0.10B 10.16%
2016-03-31 $0.94B $0.10B 10.33%
2015-12-31 $0.92B $0.10B 10.35%
2015-09-30 $0.91B $0.09B 10.08%
2015-06-30 $0.87B $0.09B 9.75%
2015-03-31 $0.83B $0.08B 9.55%
2014-12-31 $0.79B $0.08B 9.62%
2014-09-30 $0.75B $0.08B 10.03%
2014-06-30 $0.73B $0.07B 10.00%
2014-03-31 $0.73B $0.08B 10.67%
2013-12-31 $0.72B $0.08B 11.00%
2013-09-30 $0.70B $0.08B 10.98%
2013-06-30 $0.69B $0.08B 11.13%
2013-03-31 $0.66B $0.07B 10.54%
2012-12-31 $0.65B $0.07B 10.17%
2012-09-30 $0.63B $0.06B 9.74%
2012-06-30 $0.61B $0.06B 9.26%
2012-03-31 $0.59B $0.05B 8.94%
2011-12-31 $0.58B $0.05B 8.58%
2011-09-30 $0.58B $0.05B 8.52%
2011-06-30 $0.57B $0.05B 8.83%
2011-03-31 $0.54B $0.05B 8.66%
2010-12-31 $0.52B $0.05B 8.88%
2010-09-30 $0.50B $0.04B 8.85%
2010-06-30 $0.47B $0.04B 8.25%
2010-03-31 $0.46B $0.04B 8.06%
2009-12-31 $0.44B $0.03B 7.78%
2009-09-30 $0.43B $0.03B 6.50%
2009-06-30 $0.43B $0.03B 6.56%
2009-03-31 $0.42B $0.03B 6.84%
2008-12-31 $0.43B $0.03B 6.76%
2008-09-30 $0.43B $0.04B 8.43%
2008-06-30 $0.43B $0.04B 9.15%
2008-03-31 $0.43B $0.04B 9.41%
2007-12-31 $0.42B $0.05B 10.61%
2007-09-30 $0.41B $0.04B 10.73%
2007-06-30 $0.40B $0.04B 10.86%
2007-03-31 $0.38B $0.04B 11.11%
2006-12-31 $0.37B $0.04B 10.96%
2006-09-30 $0.34B $0.04B 11.63%
2006-06-30 $0.33B $0.04B 11.98%
2006-03-31 $0.33B $0.04B 12.27%
2005-12-31 $0.32B $0.04B 12.38%
2005-09-30 $0.31B $0.04B 12.14%
2005-06-30 $0.30B $0.04B 12.00%
2005-03-31 $0.29B $0.03B 11.58%
2004-12-31 $0.27B $0.03B 11.11%
2004-09-30 $0.26B $0.03B 10.89%
2004-06-30 $0.24B $0.03B 10.79%
2004-03-31 $0.22B $0.02B 10.41%
2003-12-31 $0.20B $0.02B 10.50%
2003-09-30 $0.18B $0.02B 9.50%
2003-06-30 $0.16B $0.01B 8.07%
2003-03-31 $0.15B $0.01B 7.53%
2002-12-31 $0.13B $0.01B 5.97%
2002-09-30 $0.13B $0.01B 4.80%
2002-06-30 $0.12B $0.01B 4.20%
2002-03-31 $0.12B $0.00B 2.59%
2001-12-31 $0.12B $0.00B 1.74%
2001-09-30 $0.11B $0.00B 1.75%
2001-06-30 $0.12B $0.00B 0.87%
2001-03-31 $0.12B $0.00B 0.85%
2000-12-31 $0.12B $0.00B 1.65%
2000-09-30 $0.13B $0.00B 2.38%
2000-06-30 $0.13B $0.00B 1.56%
2000-03-31 $0.13B $0.00B 3.10%
1999-12-31 $0.13B $0.01B 3.91%
1999-09-30 $0.13B $0.01B 4.72%
1999-06-30 $0.13B $0.01B 7.87%
1999-03-31 $0.13B $0.01B 7.94%
1998-12-31 $0.12B $0.01B 8.26%
1998-09-30 $0.11B $0.01B 7.96%
1998-06-30 $0.10B $0.01B 7.69%
1998-03-31 $0.09B $0.01B 8.51%
1997-12-31 $0.09B $0.01B 8.14%
1997-09-30 $0.08B $0.01B 7.69%
1997-06-30 $0.07B $0.01B 7.35%
1997-03-31 $0.06B $0.00B 6.56%
1996-12-31 $0.05B $0.00B 7.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.334B $0.925B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
United Therapeutics (UTHR) United States $25.058B 20.49
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00